Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

Title
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume 94, Issue 12, Pages 1762-1766
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2009-10-02
DOI
10.3324/haematol.2009.011528

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started